Ironwood Pharmaceuticals (IRWD) Operating Income Growth (3y) (2013 - 2026)
Ironwood Pharmaceuticals (IRWD) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.01 Bn | 20.85 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.41 Bn | 18.61 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | 40.17% |
| 10 | Ironwood Pharmaceuticals | 648.08 Mn | 427.61 Mn | - | 6.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.49% |
| Dec 31, 2025 | -53.66% |
| Sep 30, 2025 | 3.30% |
| Jun 30, 2025 | -6.62% |
| Mar 31, 2025 | -35.78% |
| Dec 31, 2024 | -17.75% |
| Sep 30, 2024 | -26.73% |
| Jun 30, 2024 | -27.34% |
| Mar 31, 2024 | -37.62% |
| Dec 31, 2023 | -9.90% |
| Sep 30, 2023 | -4.27% |
| Jun 30, 2023 | -227.45% |
| Mar 31, 2023 | 65.63% |
| Dec 31, 2022 | 11.29% |
| Sep 30, 2022 | 1.29% |
| Jun 30, 2022 | 37.14% |
| Mar 31, 2022 | 75.61% |
| Dec 31, 2021 | 23.75% |
| Sep 30, 2021 | 34.71% |
| Jun 30, 2021 | 86.01% |